USPTO trademark

CHRYSALIS BIOTHERAPEUTICS

RegisteredUSPTOWord markClass 5

"CHRYSALIS BIOTHERAPEUTICS" is a word mark owned by Chrysalis BioTherapeutics, Inc., filed at the USPTO on July 14, 2020. It is registered and covers class 5 (Pharmaceuticals).

Get this data via the API

Data current as of August 19, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since August 19, 2025
Filed: July 14, 2020
Registered: August 19, 2025
Expires: Not recorded
Application no.: 90052179
Registration no.: 7906972
Office: USPTO; United States Patent and Trademark Office
Mark type: Word mark; 1 class

Ownership

Who owns CHRYSALIS BIOTHERAPEUTICS

The owner and representative on file with the office.

Owner

Chrysalis BioTherapeutics, Inc.

Galveston, United States

Representative

Shannon T. Vale

Pirkey Barber PLLC

Goods and services

What the mark covers

The products and services CHRYSALIS BIOTHERAPEUTICS is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetic foot ulcers; Pharmaceutical preparations for accelerating healing of human tissue; Therapeutic gels intended for topical use on skin and mucous membranes, intended to accelerate the healing of skin surface wounds and diabetic foot ulcers; Pharmaceuticals for the treatment of acute radiation syndrome; Pharmaceuticals for the treatment of COVID-19; Pharmaceutical products for the prevention and treatment of Degenerative Brain Diseases and Traumatic Brain Injury (TBI)

History

What has happened so far

Steps recorded by the USPTO, newest first.

August 19, 2025Notice of registration confirmation emailed
August 19, 2025Registered-principal register
July 31, 2025Notice of acceptance of statement of use e-mailed
July 31, 2025Allowed principal register - sou accepted
July 30, 2025Teas/email correspondence entered
July 30, 2025Correspondence received in law office
July 30, 2025Teas request for reconsideration received
May 7, 2025Notification of final refusal emailed
May 7, 2025Final refusal e-mailed
May 7, 2025Su - final refusal - written

10 earlier steps on the official record.

FAQ

About CHRYSALIS BIOTHERAPEUTICS

Who owns the trademark "CHRYSALIS BIOTHERAPEUTICS"?

The USPTO trademark "CHRYSALIS BIOTHERAPEUTICS" (application 90052179) is owned by Chrysalis BioTherapeutics, Inc.

What is the status of "CHRYSALIS BIOTHERAPEUTICS"?

Its status at the USPTO is: registered.

When was "CHRYSALIS BIOTHERAPEUTICS" registered?

It was registered on August 19, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CHRYSALIS BIOTHERAPEUTICS and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d2bf2-f075-719a-a280-2340b858fa5c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d2bf2-f075-719a-a280-2340b858fa5c",
  "object": "trademark",
  "mark_text": "CHRYSALIS BIOTHERAPEUTICS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90052179",
  "filing_date": "2020-07-14",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Chrysalis BioTherapeutics, Inc.",
      "entity_id": null
    }
  ]
}